Camptosar and disease progression Patient Reports February 11, 2012

Camptosar Side Effects Report #5018378-7
Camptosar side effect was reported by a Physician from GERMANY on May 18, 2006. Male patient, 69 years of age, weighting 205.0 lb, was diagnosed with rectal cancer metastatic and was treated with Camptosar. After drug was administered, patient experienced the following side effects: disease progression, enterovesical fistula, urinary tract infection . Camptosar dosage: 420 MG (420 MG, EVERY 3 WEEKS), INTRAVENOUS. During the same period patient was treated with AVASTIN, CAPECITABINE, DELIX PLUS, MELOXICAM. Patient was hospitalized. Patient recovered.

Camptosar Side Effects Report #5099624-0
Camptosar side effect was reported by a Physician from FRANCE on Aug 23, 2006. Male patient, 64 years of age, was diagnosed with rectal cancer metastatic and was treated with Camptosar. After drug was administered, patient experienced the following side effects: disease progression, infection , nail disorder, paronychia, skin chapped. Camptosar dosage: unknown. During the same period patient was treated with ERBITUX. Patient recovered.

Camptosar Side Effects Report #5100733-8
Camptosar side effect was reported by a Physician from FRANCE on Aug 23, 2006. Male patient, 64 years of age, was diagnosed with rectal cancer metastatic and was treated with Camptosar. After drug was administered, patient experienced the following side effects: disease progression, genital lesion, infection , nail disorder, paronychia, skin chapped. Camptosar dosage: unknown. During the same period patient was treated with ERBITUX. Patient recovered.

Camptosar Side Effects Report #5101177-5
Camptosar side effect was reported by a Physician from FRANCE on Aug 23, 2006. Male patient, 64 years of age, was diagnosed with rectal cancer metastatic and was treated with Camptosar. After drug was administered, patient experienced the following side effects: disease progression, infection , nail disorder, paronychia, skin chapped. Camptosar dosage: unknown. During the same period patient was treated with ERBITUX. Patient recovered.


Camptosar Side Effects Report #5123556-2
Camptosar side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 22, 2006. Male patient, 70 years of age, weighting 161.0 lb, was diagnosed with oesophageal carcinoma and was treated with Camptosar. After drug was administered, patient experienced the following side effects: blood bilirubin increased, blood creatinine increased, dehydration, diarrhoea, disease progression, feeling abnormal, hypotension, metabolic acidosis, nausea . Camptosar dosage: (125 MG/M2. During the same period patient was treated with MITOMYCIN, PROSCAR, ATROPINE, DEXAMETHASONE, ONDANSETRON, LOPERAMIDE, APREPITANT. Patient died on 12/11/2005.

Camptosar Side Effects Report #4615000-6
Camptosar side effect was reported by a Health Professional from on Mar 07, 2005. Male patient, 44 years of age, weighting 143.3 lb, was diagnosed with metastatic neoplasm and was treated with Camptosar. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, blood lactate dehydrogenase increased, coagulopathy, disease progression, faecal occult blood positive, gastrointestinal haemorrhage. Camptosar dosage: unknown. During the same period patient was treated with GEMCITABINE, GEFITINIB, CLOPIDOGREL BISULPHATE, PROMETHAZINE HYDROCHLORIDE, OXYCODONE, ISOSORBIDE MONONITRATE, LORAZEPAM, ZOLPIDEM TARTRATE. Patient was hospitalized. Patient died on 08/10/2004.

Camptosar Side Effects Report #5356346-6
Camptosar side effect was reported by a Consumer or non-health professional from UNITED STATES on June 05, 2007. Male patient, weighting 184.1 lb, was diagnosed with metastasis and was treated with Camptosar. After drug was administered, patient experienced the following side effects: diarrhoea, disease progression, dysphagia, metastasis, regurgitation, unevaluable event. Camptosar dosage: unknown. During the same period patient was treated with ARANESP, DECADRON, DIGOXIN, FELODIPINE, LEVOTHYROXINE, LOMOTIL, FILGRASTIM, NITROGLYCERIN. Patient died on 05/27/2007.

Camptosar Side Effects Report #4745032-9
Camptosar side effect was reported by a Physician from ITALY on May 10, 2005. Male patient, 65 years of age, was diagnosed with colorectal cancer metastatic and was treated with Camptosar. After drug was administered, patient experienced the following side effects: ascites, asthenia, colorectal cancer metastatic, dehydration, disease progression, febrile neutropenia, hepatic failure, infection . Camptosar dosage: 600 MG, INTRAVENOUS. During the same period patient was treated with CETUXIMAB, ONDANSETRON HYDROCHLORIDE, DEXAMETHASONE. Patient was hospitalized. Patient died on 08/11/2004.

Camptosar Side Effects Report #5123543-4
Camptosar side effect was reported by a Physician from UNITED STATES on June 15, 2006. Male patient, weighting 116.0 lb, was diagnosed with colon cancer metastatic and was treated with Camptosar. After drug was administered, patient experienced the following side effects: abdominal pain , abdominal rigidity, ascites, colon cancer metastatic, disease progression. Camptosar dosage: 190 MG (190 MG,INTERVAL: EVERY WEEK). During the same period patient was treated with ZOFRAN, REGLAN, FAMOTIDINE, BENADRYL, PROMETHAZINE, LEUCOVORIN CALCIUM, FLUOROURACIL, AVASTIN. Patient died on 06/04/2005.


Camptosar Side Effects Report #4741875-6
Camptosar side effect was reported by a Health Professional from UNITED STATES on Feb 22, 2005. Female patient, 52 years of age, was diagnosed with colon cancer and was treated with Camptosar. After drug was administered, patient experienced the following side effects: chills, colon cancer, disease progression, dizziness , hypersensitivity, nausea , pulmonary embolism . Camptosar dosage: unknown. During the same period patient was treated with WARFARIN, POTASSIUM CHLORIDE, VALSARTAN, CARISOPRODOL, PALONOSETRON, DECADRON. Patient recovered.

Camptosar Side Effects Report #5486054-2
Camptosar side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 05, 2007. Female patient, weighting 132.3 lb, was diagnosed with breast cancer metastatic and was treated with Camptosar. After drug was administered, patient experienced the following side effects: breast cancer metastatic, disease progression. Camptosar dosage: unknown. During the same period patient was treated with ETOPOSIDE, THYROID, ASCORBIC ACID, TURMERIC, FISH OIL. Patient died on 09/26/2007.

Camptosar Side Effects Report #5327216-4
Camptosar side effect was reported by a Consumer or non-health professional from UNITED STATES on May 14, 2007. Male patient, weighting 47.18 lb, was treated with Camptosar. After drug was administered, patient experienced the following side effects: disease progression, malignant pleural effusion, respiratory distress. Camptosar dosage: 64 MG. During the same period patient was treated with VINCRISTINE SULPHATE. Patient was hospitalized. Patient died on 01/04/2005.

Camptosar Side Effects Report #5333452-3
Camptosar side effect was reported by a Consumer or non-health professional from UNITED STATES on May 22, 2007. Male patient, weighting 47.18 lb, was treated with Camptosar. After drug was administered, patient experienced the following side effects: disease progression, malignant pleural effusion, refusal of treatment by relative, respiratory distress. Camptosar dosage: 64 MG. During the same period patient was treated with VINCRISTINE SULPHATE. Patient was hospitalized. Patient died on 01/04/2005.

Camptosar Side Effects Report #5916794-X
Camptosar side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 03, 2008. Female patient was treated with Camptosar. After drug was administered, patient experienced the following side effects: disease progression. Camptosar dosage: DAILY DOSE:110MG-FREQ:ONCE A WEEK FOR 4 WEEKS. Patient died on 09/08/2008.


Camptosar Side Effects Report #6030807-9
Camptosar side effect was reported by a Health Professional from UNITED STATES on Dec 24, 2008. Female patient was treated with Camptosar. After drug was administered, patient experienced the following side effects: disease progression. Camptosar dosage: 210 MG, EVERY 2 WEEKS. Patient died on 10/29/2008.

Camptosar Side Effects Report #6136540-7
Camptosar side effect was reported by a Health Professional from UNITED STATES on Mar 20, 2009. Female patient was treated with Camptosar. After drug was administered, patient experienced the following side effects: disease progression. Camptosar dosage: 200 MG, EVERY 2 WEEKS. Patient died.